Get started
GLAXOSMITHKLINE PHARMACEUTICALGLAXOSMITHKLINE PHARMACEUTICALGLAXOSMITHKLINE PHARMACEUTICAL

GLAXOSMITHKLINE PHARMACEUTICAL

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

GLAXO chart


Full chart

GLAXO upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪558.88 B‬ INR
Dividend yield (indicated)
1.27%
Price to earnings Ratio (TTM)
60.60
Basic EPS (TTM)
54.75 INR
Net income (FY)
‪9.28 B‬ INR
Revenue (FY)
‪37.49 B‬ INR
Shares float
‪39.69 M‬
Beta (1Y)
0.52

Employees


Employees (FY)
‪3.11 K‬
Change (1Y)
−98 −3.05%
Revenue / Employee (1Y)
‪12.04 M‬ INR
Net income / Employee (1Y)
‪2.98 M‬ INR

About GLAXOSMITHKLINE PHARMA LTD


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Bhushan Akshikar
Website
gsk-india.com
Headquarters
Mumbai
Founded
1924
ISIN
INE159A01016
FIGI
BBG000CRN6Y0
GlaxoSmithKline Pharmaceuticals Ltd. engages in the business of manufacturing, distributing and trading in pharmaceuticals. Its prescription medicines range across therapeutic areas such as anti-infective, dermatology, gynecology, diabetes, cardiovascular disease and respiratory diseases. The vaccines products include prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenza, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, streptococcus pneumonia and others. The company was founded in 1924 and is headquartered in Mumbai, India.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

GLAXO news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as GLAXO.

Frequently Asked Questions


The current price of GLAXO is 3,299.05 INR — it has decreased by −0.59% in the past 24 hours. Watch GLAXOSMITHKLINE PHARMACEUTICAL stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange GLAXOSMITHKLINE PHARMACEUTICAL stocks are traded under the ticker GLAXO.
GLAXO stock has fallen by −4.60% compared to the previous week, the month change is a 13.47% rise, over the last year GLAXOSMITHKLINE PHARMACEUTICAL has showed a 24.03% increase.
We've gathered analysts' opinions on GLAXOSMITHKLINE PHARMACEUTICAL future price: according to them, GLAXO price has a max estimate of 3,500.00 INR and a min estimate of 2,600.00 INR. Watch GLAXO chart and read a more detailed GLAXOSMITHKLINE PHARMACEUTICAL stock forecast: see what analysts think of GLAXOSMITHKLINE PHARMACEUTICAL and suggest that you do with its stocks.
GLAXO reached its all-time high on Jun 2, 2025 with the price of 3,396.25 INR, and its all-time low was 231.05 INR and was reached on Oct 29, 2003. View more price dynamics on GLAXO chart.
See other stocks reaching their highest and lowest prices.
GLAXO stock is 2.25% volatile and has beta coefficient of 0.52. Track GLAXOSMITHKLINE PHARMACEUTICAL stock price on the chart and check out the list of the most volatile stocks — is GLAXOSMITHKLINE PHARMACEUTICAL there?
Today GLAXOSMITHKLINE PHARMACEUTICAL has the market capitalization of ‪558.88 B‬, it has increased by 8.19% over the last week.
Yes, you can track GLAXOSMITHKLINE PHARMACEUTICAL financials in yearly and quarterly reports right on TradingView.
GLAXOSMITHKLINE PHARMACEUTICAL is going to release the next earnings report on Jul 28, 2025. Keep track of upcoming events with our Earnings Calendar.
GLAXOSMITHKLINE PHARMACEUTICAL revenue for the last quarter amounts to ‪9.74 B‬ INR, despite the estimated figure of ‪9.94 B‬ INR. In the next quarter, revenue is expected to reach ‪8.38 B‬ INR.
GLAXO net income for the last quarter is ‪2.63 B‬ INR, while the quarter before that showed ‪2.30 B‬ INR of net income which accounts for 14.35% change. Track more GLAXOSMITHKLINE PHARMACEUTICAL financial stats to get the full picture.
Yes, GLAXO dividends are paid annually. The last dividend per share was 42.00 INR. As of today, Dividend Yield (TTM)% is 1.27%. Tracking GLAXOSMITHKLINE PHARMACEUTICAL dividends might help you take more informed decisions.
GLAXOSMITHKLINE PHARMACEUTICAL dividend yield was 1.46% in 2024, and payout ratio reached 76.71%. The year before the numbers were 1.65% and 91.89% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Jun 14, 2025, the company has ‪3.11 K‬ employees. See our rating of the largest employees — is GLAXOSMITHKLINE PHARMACEUTICAL on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GLAXOSMITHKLINE PHARMACEUTICAL EBITDA is ‪11.77 B‬ INR, and current EBITDA margin is 31.73%. See more stats in GLAXOSMITHKLINE PHARMACEUTICAL financial statements.
Like other stocks, GLAXO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GLAXOSMITHKLINE PHARMACEUTICAL stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GLAXOSMITHKLINE PHARMACEUTICAL technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GLAXOSMITHKLINE PHARMACEUTICAL stock shows the buy signal. See more of GLAXOSMITHKLINE PHARMACEUTICAL technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.